動物用診断薬の世界市場-2023年～2030年

市場概要

世界の動物用診断薬市場は、2022年に71億米ドルに達し、2030年には136億米ドルに達する好成長が予測されています。世界の動物用診断薬市場は、予測期間中（2023-2030年）に8.7%のCAGRを示すと予測されています。

動物用診断薬は動物の健康にとって極めて重要であり、健康問題が深刻化する前に発見し、迅速な診断と治療計画を可能にします。従来の診断は、血液、組織、尿、糞便を検査し、タンパク質、抗体、病気、または健康全般の一般的なマーカーの存在を確認するものです。デジタル診断では、人間の専門家が見落としがちな健康データの動向を発見し、病気の早期診断に新たな道を開くことで、テクノロジーの予防能力を発揮します。人工知能やその他の最先端アプローチは、増え続けるデータ量から危険パターンを発見する可能性を高めます。

さらに、獣医学的疾患の増加、世界中で飼育されるペットの数の増加などが、獣医学的診断市場規模の拡大に寄与しています。米国やカナダのような国々での技術進歩の大規模な上昇のため、市場は、Ringbio、Virbac、PetDx、およびその他の活動のような重要な主要プレーヤーが市場で積極的に動作している北米地域からの需要の増加を目の当たりにしています。

市場力学

世界のペット飼育数の増加が市場成長を押し上げる

世界中で飼育されるペットの数が増加していることが、世界の動物用診断薬市場を活性化させています。例えば、ASPCAによると、毎年約630万匹のコンパニオンアニマルが米国の動物保護施設に入所しています。そのうち約310万匹が犬で、340万匹が猫です。毎年約410万匹の保護動物が養子に出される（犬200万匹、猫210万匹）。

さらに、犬や猫などのペットは、伴侶となり、精神的な支えとなることでも知られています。特に、COVID-19の大流行のような困難な時期には、人々は家で過ごす時間が長くなり、孤立感を感じていたため、ペットの同伴を切望していました。多くの研究が、ペットとの関わりがストレスや不安、うつ病に対処するのに役立つことを示しています。

ペットが精神衛生に役立つという認識が広まるにつれ、幸福感を高めるためにペットを求める人が増えました。ソーシャルメディア・プラットフォームでペットに焦点を当てたものが人気を博したため、ペットの飼育が増加しました。ペットの愛らしい動画や写真を見て、ペットを飼いたいと思う人が増えました。こうした要因が市場の成長を後押ししています。

ペット動物の病気の有病率の上昇

世界的に、ペット動物の病気の有病率の上昇と人間への感染が市場拡大を支えています。人獣共通感染症の有病率の上昇と人への感染、ペットの飼育数の増加と獣医専門家の数、動物用診断の研究増加が市場拡大を促進しています。

例えば、Faculty Reviews 2022に掲載された研究によると、ヒトの感染症の63％以上は人獣共通感染症が起源であり、残りの45％は人獣共通感染症以外の感染源から発症したか、ヒトと共進化したものです。最近、人獣共通感染症を起源とするいくつかの病気が大流行し、世界の人口に損害を与えています。その結果、ペット動物の病気の増加が市場の成長に寄与しています。

ペットケア費用の増加と獣医師不足

しかし、ペット医療費の増大と獣医師不足は、動物用診断薬市場の成長を阻害すると予想されます。米国労働統計局の2021年5月の職業別雇用・賃金によると、米国でペットを飼っている世帯が9,050万世帯あるのに対し、獣医師は7万7,260人しか開業していません。

また、米国動物虐待防止協会によれば、ペットを飼うのにかかる平均費用は、ペットの種類や大きさによって、年間700米ドルから1,10米0ドルに達します。そのため、予測期間中の世界の動物用診断薬市場の成長は鈍化すると思われます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 世界のペット飼育頭数の増加が市場成長を押し上げる
    • ペット動物の疾病の増加
  • 抑制要因
    • ペットの医療費の増加と獣医師不足
  • 機会
    • 携帯型・迅速診断装置に対する需要の高まり
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析

第6章 COVID-19分析

第7章 製品タイプ別

• 分析装置
• 消耗品

第8章 動物タイプ別

• 家畜
• コンパニオンアニマル

第9章 技術別

• 分子診断薬
• 免疫診断学
• 臨床生化学
• 血液学
• その他の技術

第10章 用途別

• 感染症
• 自己免疫疾患
• 内分泌・腫瘍学
• 骨・ミネラル疾患
• その他

第11章 エンドユーザー別

• 参考検査室
• 動物病院・クリニック
• PoC／院内検査
• その他

第12章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋
• 中東・アフリカ

第13章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A分析

第14章 企業プロファイル

• Zoetis
  • 企業概要
  • 製品タイプポートフォリオと内容
  • 財務概要
  • 主な動向
• Thermo Fisher Scientific
• Covetrus, Inc.
• PetDx
• HORIBA UK Limited
• Ringbio,
• Virbac
• IDVet
• Abaxis
• Heska Corporation

第15章 付録

Market Overview

The global veterinary diagnostics market reached US$ 7.1 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 13.6 billion by 2030. The global veterinary diagnostic smarket is expected to exhibita CAGR of 8.7% during the forecast period (2023-2030).

Veterinary diagnostics are crucial for animal health, detecting health issues before they become serious and allowing for faster diagnosis and treatment planning. Traditional diagnosis is the examination of blood, tissue, urine, or faeces for the presence of proteins, antibodies, disease, or general markers of overall health. Digital diagnostics unleash the technology's preventative capacity by spotting trends in wellness data that human specialists may overlook, opening up new avenues for early disease diagnosis. Artificial intelligence and other cutting-edge approaches mean more potential to spot danger patterns in ever-increasing data volumes.

Additionally, the rise of veterinary diseases, growing number of pets adopted worldwide and other factors helps to grow the veterinary diagnostics market size. Due to the massive rise in technological advancements in countries like the U.S. and Canada, the market is seeing an increase in demand from North American regions with significant key players like Ringbio, Virbac, PetDx, and others actively operating in the market.

Market Dynamics

Increasing Number of Pets Adopted Worldwide will Rise the Market Growth

The growing number of pets adopted worldwide fuels the global veterinary diagnostics market. For instance, according to ASPCA, approximately 6.3 million companion animals enter U.S. animal shelters nationwide every year. Of those, approximately 3.1 million are dogs and 3.4 million are cats. Approximately 4.1 million shelter animals are adopted each year (2 million dogs and 2.1 million cats).

Additionally, Pets, such as dogs and cats, are also known for offering companionship and emotional support. Especially during difficult times, such as the COVID-19 pandemic, when people were spending more time at home and feeling isolated, individuals craved the company of a pet. Numerous studies have demonstrated that engaging with pets can help people cope with stress, anxiety, and depression.

As individuals become more aware of the benefits of pets for mental health, more people sought out pets to boost their well-being. Pet adoption has increased due to the popularity of pet-focused material on social media platforms. People were more interested in owning pets after seeing adorable and comforting pet videos and photographs. Thus above factors helps to drive the market growth.

The Rising Prevalence of Pet Animal Diseases

Globally, the rising prevalence of pet animal illnesses and their transmission to humans supported market expansion. The rising prevalence of zoonotic illnesses and their transmission to humans, increased pet adoptions and the number of veterinary healthcare professionals, and more research into veterinary disease diagnosis are driving market expansion.

For instance, according to a study published in the Faculty Reviews 2022, more than 63% of human infections have zoonotic origins, whereas the other 45% have either developed from non-zoonotic sources or co-evolved with humans. Several zoonotic-origin illnesses have recently resulted in an outbreak and have damaged the global human population. As a result, the rise of pet animal diseases contributes to market growth.

The Increasing Pet Care Costs and Shortage of Veterinarians

However, the increasing pet care costs and shortage of veterinarians are anticipated to hinder the growth of the veterinary diagnostics market. The U.S. Bureau Of Labor Statistics Occupational Employment and Wages, in May 2021, indicated that only 77,260 veterinarians are practicing for the 90.5 million U.S households with pets.

Also, the average cost of owning a pet can range from $700 to $1,100 per year, as per the type and size of pet, according to the American Society for the Prevention of Cruelty to Animals. Thus, it will slow the global veterinary diagnostics market growth in the forecast period.

Segment Analysis

The global veterinary diagnostics market is segmented based on product type, animal type, technology, application, end user and region.

The Analyzers Segment Accounted for Approximately 41.07% of the Veterinary DiagnosticsMarket Share

Veterinary diagnostics analyzers are extremely important in the field of veterinary medicine. These advanced tools are meant to perform numerous diagnostic tests and analyses on animal samples, assisting veterinarians in accurately diagnosing diseases and monitoring their patients' health state.

Additionally, the strategies followed by companies helps to boost the segment growth. For instance, on December 21, 2022, EKF Diagnostics, a global in vitro diagnostics firm, has announced the launch of a new version of their Lactate Scout analyzer, specifically tailored for use in veterinary settings. Lactate Scout Vet employs the same tried-and-true technology that was first created to equip professional sports coaches and athletes with a precise and user-friendly handheld lactate test.

Additionally, in Feburary 2023, VolitionRx Limited, an epigenetics firm, has announced that their Nu.Q Vet Cancer Test is currently available for pre-order through Heska Corporation to veterinarians at the point-of-care. Heska's Nu.Q Canine Cancer Screen and Monitor Test will be run using Heska's proprietary Element i + Immunodiagnostic Analyzer, a point-of-care platform that gives veterinarians with on-site testing that is speedy, accurate, low cost, and simple to use. Thus, the aforementioned variables drive segment expansion.

Geographical Penetration

North America Accounted for Approximately 43.4% of the Market Share in 2022

Growing pet adoptions, increased expenditure on pet health, and product releases by companies all contribute to the region's success. For instance, in July 2022, PSIvet, the nation's largest veterinary group purchasing organisation, has announced an agreement with Bionote USA, a developer of quantitative, point-of-care veterinary analyzers and biomarker assays.

The collaboration will lower the cost of Bionote USA's Vcheck series of analyzers and tests for PSIvet's 5,000-plus veterinary practises. The Vcheck V200 analyzer and tests can be utilised as a supplement to a veterinary clinic's point-of-care lab for speedier diagnosis and treatment plan initiation, as well as significant cost savings per test.

Additionally, on April 19, 2022, Zoetis announced the inclusion of artificial intelligence (AI) blood smear testing to its multi-purpose platform, Vetscan ImagystTM, as its latest diagnostic breakthrough. Vetscan Imagyst, which will be available in September 2020, is a first-of-its-kind technology with a wide range of applications, including AI faecal analysis, digital cytology image transfer, and now AI blood smear - ultimately assisting veterinarians in broadening in-clinic diagnostic offerings to provide the best possible care for dogs and cats. Thus, the aforementioned reasons promote the region's growth.

Competitive Landscape

The major global players in the veterinary diagnostics market Zoetis, Thermo Fisher Scientific, Covetrus, Inc, PetDx, HORIBA UK Limited, Ringbio, Virbac, IDVet, Abaxis, Heska Corporation and others.

COVID-19 Impact Analysis

COVID- 19 pandemic has positively impacted the global veterinary diagnostics market growth. Since the pandemic, there has been an increase in pet adoption, and more attention has been paid by the pet owner to the health of their pets. For instance, a total of 3.9 million pets were insured in the U.S. at year-end 2021, showing a 28 percent rise since 2020, according to the North American Pet Health Insurance Association's State of the Industry Report 2022.

As per the Pet Food Manufacturers' Association, a total of 3.2 million households in the UK have acquired a pet since the start of the pandemic. Thus, positively impacting the global veterinary diagnostics market growth.

By Product Type

• Analyzers
• Consumables

By Animal Type

• Livestock
• Companion

By Technology

• Molecular Diagnostics
• Immunodiagnostics
• Clinical Biochemistry
• Hematology
• Other Technologies

By Application

• Infectious Disease
• Autoimmune Disorder
• Endocrinology & Oncology
• Bone and Mineral diseases
• Others

By End User

• Reference Laboratories
• Veterinary Hospitals & Clinics
• Point of care/ In-house testing
• Others

By Region

• North America

U.S.

Canada

Mexico

• Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

• South America

Brazil

Argentina

Rest of South America

• Asia-Pacific

China

India

Japan

Australia

Rest of Asia-Pacific

• Middle East and Africa

Key Developments

• On June 29, 2023, the H50V is a new 5-part veterinary solution for cost-effective diagnostics that Boule Diagnostics is offering for the European market. It has 13 preloaded animal profiles and over 30 analysed parameters, making it a versatile system that can be used in a variety of veterinary clinics and laboratories.
• In August 2022, PepiPets, a pet firm focused on at-home companion animal care, is launching a new mobile diagnostic testing service. According to a corporate announcement, the launch of this new service will allow clients to undergo diagnostic testing for their pets at home.
• On November 03, 2021, With the acquisition of French distribution company DMV Imaging, FUJIFILM Europe hopes to broaden its customer offering with veterinary diagnostic products and services. With this acquisition, Fujifilm hopes to establish itself as a leading veterinary diagnostics company in France, offering a comprehensive diagnostics solution that includes not only point-of-care laboratory diagnostics but also a variety of imaging diagnostic solutions for Billions of pets served by veterinarians.

Why Purchase the Report?

• To visualize the global veterinary diagnostics market segmentation based on product type, animal type, technology, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of veterinary diagnostics market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global veterinary diagnostics market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Animal Type
• 3.3. Snippet by Technology
• 3.4. Snippet by Application
• 3.5. Snippet by End User
• 3.6. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing number of pets adopted worldwide will rise the market growth
    • 4.1.1.2. The rising prevalence of pet animal diseases
  • 4.1.2. Restraints
    • 4.1.2.1. The increasing pet care costs and shortage of veterinarians
  • 4.1.3. Opportunity
    • 4.1.3.1. Rising demand for portable and rapid diagnostic devices
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's 5 Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID-19
  • 6.1.2. Scenario During COVID-19
  • 6.1.3. Scenario Post COVID-19
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. ByProduct Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 7.1.2. Market Attractiveness Index, By Product Type
• 7.2. Analyzers *
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Consumables

8. ByAnimal Type

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
  • 8.1.2. Market Attractiveness Index, By Animal Type
• 8.2. Livestock*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Companion

9. ByTechnology

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 9.1.2. Market Attractiveness Index, By Technology
• 9.2. Molecular Diagnostics *
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Immunodiagnostics
• 9.4. Clinical Biochemistry
• 9.5. Hematology
• 9.6. Other Technologies

10. By Application

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.1.2. Market Attractiveness Index, By Application
• 10.2. Infectious Disease *
  • 10.2.1. Introduction
  • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 10.3. Autoimmune Disorder
• 10.4. Endocrinology& Oncology
• 10.5. Bone and Mineral diseases
• 10.6. Others

11. ByEnd-User

• 11.1. Introduction
  • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 11.1.2. Market Attractiveness Index, By End-User
• 11.2. Reference Laboratories *
  • 11.2.1. Introduction
  • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 11.3. Veterinary Hospitals & Clinics
• 11.4. Point of care/ In-house testing
• 11.5. Others

12. By Region

• 12.1. Introduction
  • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 12.1.2. Market Attractiveness Index, By Region
• 12.2. North America
  • 12.2.1. Introduction
  • 12.2.2. Key Region-Specific Dynamics
  • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
  • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 12.2.8.1. U.S.
    • 12.2.8.2. Canada
    • 12.2.8.3. Mexico
• 12.3. Europe
  • 12.3.1. Introduction
  • 12.3.2. Key Region-Specific Dynamics
  • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
  • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 12.3.8.1. Germany
    • 12.3.8.2. U.K.
    • 12.3.8.3. France
    • 12.3.8.4. Spain
    • 12.3.8.5. Italy
    • 12.3.8.6. Rest of Europe
• 12.4. South America
  • 12.4.1. Introduction
  • 12.4.2. Key Region-Specific Dynamics
  • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
  • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 12.4.8.1. Brazil
    • 12.4.8.2. Argentina
    • 12.4.8.3. Rest of South America
• 12.5. Asia-Pacific
  • 12.5.1. Introduction
  • 12.5.2. Key Region-Specific Dynamics
  • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
  • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 12.5.8.1. China
    • 12.5.8.2. India
    • 12.5.8.3. Japan
    • 12.5.8.4. Australia
    • 12.5.8.5. Rest of Asia-Pacific
• 12.6. Middle East and Africa
  • 12.6.1. Introduction
  • 12.6.2. Key Region-Specific Dynamics
  • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
  • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

13. Competitive Landscape

• 13.1. Competitive Scenario
• 13.2. Market Positioning/Share Analysis
• 13.3. Mergers and Acquisitions Analysis

14. Company Profiles

• 14.1. Zoetis*
  • 14.1.1. Company Overview
  • 14.1.2. Product TypePortfolio and Description
  • 14.1.3. Financial Overview
  • 14.1.4. Key Developments
• 14.2. Thermo Fisher Scientific
• 14.3. Covetrus, Inc.
• 14.4. PetDx
• 14.5. HORIBA UK Limited
• 14.6. Ringbio,
• 14.7. Virbac
• 14.8. IDVet
• 14.9. Abaxis
• 14.10. Heska Corporation

LIST NOT EXHAUSTIVE

15. Appendix

• 15.1. About Us and Services
• 15.2. Contact Us